Answers are grounded in this paper and cite their sources.
Curative direct-acting antivirals for chronic hepatitis C provide a net economic benefit to Medicaid in less than 1 year. Cumulative savings to date have exceeded $15 billion.
No takes yet. Share an insight, caveat, or question.
M. Christopher Roebuck (2022) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: